Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma

NCT02513160 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

713

Enrollment

INDUSTRY

Sponsor class

Conditions

Persistent Asthma

Interventions

DRUG: Beclomethasone Dipropionate 640
DRUG: Placebo
DRUG: Beclomethasone dipropionate via 320 mcg BAI
DRUG: albuterol/salbutamol
DRUG: Beclomethasone dipropionate via 320 mcg MDI

Sponsor

Teva Branded Pharmaceutical Products R&D, Inc.